Moreover, IMD administration significantly decreased FBG, fasting serum insulin levels, insulin resistance, serum triglycerides, and LDL-C levels, and it increased the serum HDL-C levels of rats (Table S1). The gene discussed is INS; the disease is Insulin resistance.